UNI-EN 95:Notification - current report 95
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 95 | / | 2016 | |||||||
| Date of issue: | 2016-10-10 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification - current report 95 | |||||||||||
| Official market - legal basis | |||||||||||
| art. 17. 1 MAR. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| In accordance with the provisions of art. 27, para 3 from Ordinance 2 on the prospectuses Sopharma AD and due to change in the internet address of the corporate website of the company, Sopharma hereby advises that the company published and disseminated information to the public in the last 12 months in the Republic of Bulgaria and in other member states in the following ways: 1. Through the unified information system of the Bulgarian Stock Exchange E-register - www.fsc.bg; 2. Through X3news information agency - http://www.x3news.com; 3. Through the electroinc media Investor.bg - www.investor.bg; 4. Through Infostock bulletin – www.infostock.bg/; 5. Through the internet web site of the company - http://www.sopharmagroup.bg ; http://www.sopharmagroup.com http://www.sopharmagroup.net http://www.sopharmagroup.eu 6. Through the Polish Financial Supervision Commission system ESPI; 7. Through the Polish Press Agency – www.pap.pl | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Notification - current report 95.doc Notification - current report 95.doc | Notification - current report 95 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2016-10-10 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 6.5 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
